Europe Veterinary Medicine Market Size & Outlook, 2026-2033
Global Market
Related Markets
Europe veterinary medicine market highlights
- The Europe veterinary medicine market generated a revenue of USD 13,558.6 million in 2025.
- The market is expected to grow at a CAGR of 10.4% from 2026 to 2033.
- In terms of segment, pharmaceuticals was the largest revenue generating product in 2025.
- Biologics is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Sweden is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 13,558.6 million |
| Market revenue in 2033 | USD 29,465.9 million |
| Growth rate | 10.4% (CAGR from 2026 to 2033) |
| Largest segment | Pharmaceuticals |
| Fastest growing segment | Biologics |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biologics, Pharmaceuticals, Medicated Feed Additives |
| Key market players worldwide | Zoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago |
Other key industry trends
- In terms of revenue, Europe region accounted for 26.3% of the global veterinary medicine market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 26,007.9 million by 2033.
Europe veterinary medicine market held the second-largest share in 2023. It is one of the leading regions with advanced technologies and established market players, resulting in improved veterinary facilities.
For instance, the European Board of Veterinary Specialization (EBVS) focuses on veterinary specialization. According to the European Medicines Agency, modified regulations came into effect in January 2022, which was expected to simplify the set norms and alleviate the burden on pharmaceutical companies, thereby creating lucrative growth opportunities.
Furthermore, trade organizations, such as the European Free Trade Association (EFTA), an intergovernmental organization of Liechtenstein, Iceland, Norway, & Switzerland, facilitated trade between countries and increased growth opportunities in the region. Moreover, a high proportion of insured pets is fueling the Europe veterinary medicine market.
No credit card required*
Publish Date: Apr 06, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Veterinary Medicine Market Scope
Veterinary Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Zoetis Inc Class A | View profile | 14,100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | www.zoetis.com |
| Virbac SA | View profile | 5,400 | 2065m LID, 1 ere avenue, Carros, France, 06516 | www.virbac.com |
| Merck & Co Inc | View profile | 72,000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | www.merck.com |
| Elanco Animal Health Inc | View profile | 9,800 | 2500 Innovation Way, Greenfield, IN, United States, 46140 | www.elanco.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | www.boehringer-ingelheim.com/ |
| Dechra Pharmaceuticals | View profile | 501-1000 | Northwich, Cheshire, United Kingdom, Europe | www.dechra.com |
| Ceva Santé Animale | View profile | 5001-10000 | Libourne, Aquitaine, France, Europe | www.ceva.us |
| Phibro Animal Health Corp Class A | View profile | 1,920 | 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712 | www.pahc.com |
| Biogenesis Bago | View profile | 501-1000 | Garín, Buenos Aires, Argentina, South America | www.biogenesisbago.com/en/ |
| Bimeda Ireland | View profile | 1001-5000 | Tallaght, Dublin, Ireland, Europe | www.bimeda.ie/ |
Europe Veterinary Medicine Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Medicine Market Outlook will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 63.66% in 2025.
Horizon Databook has segmented the Europe veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2021 to 2033.
Europe veterinary medicine market held the second-largest share in 2023. It is one of the leading regions with advanced technologies and established market players, resulting in improved veterinary facilities.
For instance, the European Board of Veterinary Specialization (EBVS) focuses on veterinary specialization. According to the European Medicines Agency, modified regulations came into effect in January 2022, which was expected to simplify the set norms and alleviate the burden on pharmaceutical companies, thereby creating lucrative growth opportunities.
Furthermore, trade organizations, such as the European Free Trade Association (EFTA), an intergovernmental organization of Liechtenstein, Iceland, Norway, & Switzerland, facilitated trade between countries and increased growth opportunities in the region. Moreover, a high proportion of insured pets is fueling the Europe veterinary medicine market.
- Europe Veterinary Medicine Market Product Outlook (Revenue, USD Million , 2021-2033)
- Biologics
- Pharmaceuticals
- Medicated Feed Additives
- Europe Veterinary Medicine Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
- Companion Animals
- Production Animals
- Europe Veterinary Medicine Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
- Oral
- Other Routes
- Injectable
- Topical
- Europe Veterinary Medicine Market Distribution Channel Outlook (Revenue, USD Million , 2021-2033)
- E-commerce
- Offline Retail Stores
- Others
- Veterinary Hospitals & Clinics
Reasons to subscribe to Veterinary Medicine Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Medicine Market Outlook databook
- Our clientele includes a mix of Veterinary Medicine Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Veterinary Medicine Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Veterinary Medicine Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Veterinary Medicine Market, 2021-2033 (US$M)
Europe veterinary medicine market statistics, by product, 2021-2033 (US$M)
